MicroPort CardioFlow Medtech Corp. ( (HK:2160) ) has provided an announcement.
MicroPort CardioFlow Medtech Corp. has revised and adopted new terms of reference for its Nomination Committee, which is responsible for identifying and recommending candidates for the company’s board of directors. The committee will ensure compliance with applicable laws and listing standards, and it will consist of a majority of independent non-executive directors, including at least one director of a different gender. This move is likely to enhance the company’s governance and ensure a diverse and independent board, potentially strengthening its market position and stakeholder confidence.
More about MicroPort CardioFlow Medtech Corp.
MicroPort CardioFlow Medtech Corp. is a company incorporated in the Cayman Islands, operating in the medical technology industry. It focuses on developing and providing innovative cardiovascular devices and solutions.
YTD Price Performance: 66.18%
Average Trading Volume: 3,654,845
Technical Sentiment Signal: Sell
Current Market Cap: HK$2.65B
For an in-depth examination of 2160 stock, go to TipRanks’ Stock Analysis page.